A New Case of Association of Megaloblastic Anemia and Pancytopenia of Infants

Clinical Laboratory
|October 16, 2023
PubMed

Insights

Vitamin B12 deficiency can cause megaloblastic anemia in exclusively breastfed infants. Early diagnosis and treatment are crucial for infant development and recovery.

Area of Science:

  • Pediatric Hematology
  • Nutritional Deficiencies
  • Infant Health

Background:

  • Vitamin B12 (cobalamin) deficiency is rare in infants but can occur in exclusively breastfed infants of vegetarian mothers.
  • Megaloblastic anemia in infants may manifest as irritability and generalized weakness.

Observation:

  • A nine-month-old exclusively breastfed infant presented with irritability, developmental delay, and feeding difficulties.
  • Initial blood work revealed pancytopenia, with low Vitamin B12 levels in both the infant and mother.

Findings:

  • The infant was diagnosed with Vitamin B12 deficiency leading to megaloblastic anemia.
  • Treatment involved addressing the deficiency, resulting in normalized hematological parameters and developmental progress.

Implications:

  • Highlights the importance of considering Vitamin B12 deficiency in the differential diagnosis of anemia in exclusively breastfed infants.
  • Emphasizes the need for maternal nutritional assessment and timely intervention to prevent severe infant health outcomes.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
745
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
956
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
320
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
957
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
167